Epizyme: A Promising Long-Term Pick For The Healthcare Investor [Seeking Alpha]
Epizyme, Inc. (EPZM)
Last epizyme, inc. earnings: 2/24 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
epizyme.com
Company Research
Source: Seeking Alpha
Epizyme: A Promising Long-Term Pick For The Healthcare Investor Summary FDA's approval of Tazemetostat would be a significant advance in the field of epigenetics. Label expansion of Tazemetostat may open up significant revenue opportunities. Epizyme can prove to be a promising acquisition target. There are company-specific risks to be considered prior to investing in Epizyme. I had last recommended Epizyme ( EPZM promising pick In this backdrop, I will be explaining why I believe there is still a huge upside potential for the long-term investor in this epigenetics focused stock. FDA approval of Tazemetostat will ensure a significant first-mover advantage to Epizyme in the upcoming field of Epigenetics Today, Cancer epigenetics Epizyme is focused on the epigenetic mechanism of histone modification and is developing therapeutics that can inhibit certain aberrant histone methylation patterns. This is expected to reduce tumor cell proliferation. Tazemetostat inhibits wild-type and mutated
Show less
Read more
Impact Snapshot
Event Time:
EPZM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EPZM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EPZM alerts
High impacting Epizyme, Inc. news events
Weekly update
A roundup of the hottest topics